Emkay Global Financial's research report on Westlife Foodworld
Similar to JUBI, WESTLIFE reported a miss across all fronts – EBITDA came in 8-10% lower and PAT missed estimates by ~30%. SSG was weak at 1%, but relatively better than that of peers, as WESTLIFE indicated market-share gains. WESTLIFE expects gradual SSG recovery going ahead, but growth investments are likely to continue as the company sees this as a blip (2027 guidance was maintained). We remain confident about faster SSG recovery for WESTLIFE, given its historical SSG outperformance, multiple brand/channel extensions and focused strategy on catering more consumer occasions through the Burger, Chicken and Café offerings. Lower ticket size for WESTLIFE should also lend support in a weak macro environment.
Outlook
Our EBITDA estimates get cut by 6-11%, but we maintain our BUY rating with TP of Rs1,040/share (32x Dec-25E EBITDA), given our expectations of strong revenue/EBITDA CAGR of 15%/23% over FY23-26E. The stock has corrected 10% from its peak and further correction should be taken as an opportunity to enter.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!